Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer

The neoadjuvant use of immune checkpoint inhibitors (ICI) in resectable non-small cell lung cancer (NSCLC) is being increasingly adopted, but questions about the most appropriate applications remain. Although patients with resectable NSCLC are often treated with surgery and adjuvant chemotherapy or...

Descripción completa

Detalles Bibliográficos
Autores principales: Riano, Ivy, Abuali, Inas, Sharma, Aditya, Durant, Jewelia, Dragnev, Konstantin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963056/
https://www.ncbi.nlm.nih.gov/pubmed/37259381
http://dx.doi.org/10.3390/ph16020233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963056/
https://www.ncbi.nlm.nih.gov/pubmed/37259381
http://dx.doi.org/10.3390/ph16020233

Ejemplares similares